Identification of circ_0058357 as a regulator in non‐small cell lung cancer cells resistant to cisplatin by miR ‐361‐3p/ ABCC1 axis
出版年份 2021 全文链接
标题
Identification of circ_0058357 as a regulator in non‐small cell lung cancer cells resistant to cisplatin by
miR
‐361‐3p/
ABCC1
axis
作者
关键词
-
出版物
Thoracic Cancer
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-09-15
DOI
10.1111/1759-7714.14150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis
- (2021) Youqing Zhong et al. Cancer Biomarkers
- hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis
- (2021) Dongshan Wei et al. Molecular Medicine Reports
- MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway
- (2020) Bin Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer
- (2020) Zihao Pan et al. Molecular Cancer
- CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)
- (2020) Yongsheng Zhao et al. Cancer Cell International
- Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells
- (2020) Huasong Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4
- (2020) Songhui Zhou et al. ONCOLOGY REPORTS
- EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis
- (2020) Chi-Chen Fan et al. Redox Biology
- Circular RNA PRMT5 confers cisplatin‐resistance via miR‐4458/REV3L axis in non‐small‐cell lung cancer
- (2020) Jun Pang et al. CELL BIOLOGY INTERNATIONAL
- CircRNAs in anticancer drug resistance: recent advances and future potential
- (2020) Tianwei Xu et al. Molecular Cancer
- The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer
- (2020) Bianjiang Liu et al. Cell Death & Disease
- MicroRNA-361-3p Inhibit the Progression of Lymphoma by the Wnt/β-Catenin Signaling Pathway
- (2020) Hui Zhou et al. Cancer Management and Research
- Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer
- (2019) Lijian Chen et al. Molecular Cancer
- Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
- (2019) Michela Terlizzi et al. PHARMACOLOGY & THERAPEUTICS
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non‐small cell lung cancer cells via the miR‐361‐3p/FRAT1 axis
- (2019) Xiaomei Li et al. Thoracic Cancer
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
- (2018) Haishan Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma
- (2018) Jisheng Hu et al. Cell Death & Disease
- Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
- (2017) Wei Ma et al. Experimental and Therapeutic Medicine
- Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
- (2016) Antonio Rossi et al. Expert Review of Anticancer Therapy
- MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC
- (2016) Wei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Functions of MicroRNAs: mRNA Decay and Translational Repression
- (2015) Hiro-oki Iwakawa et al. TRENDS IN CELL BIOLOGY
- MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer
- (2015) Jun Li et al. TUMOR BIOLOGY
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Circular RNAs are a large class of animal RNAs with regulatory potency
- (2013) Sebastian Memczak et al. NATURE
- Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
- (2011) Qi Wang et al. EXPERIMENTAL LUNG RESEARCH
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started